Cellugy
Developing game-changing alternatives to fossil-based plastics
Developing game-changing alternatives to fossil-based plastics
formerly known as Arxx Therapeutics, develops a first-in-class monoclonal antibody with a unique mechanism of action targeting non-resolving tissue fibrosis
Developing diagnostic self-tests
Bringing safe and affordable drinking water to low income communities.